Philadelphia, Pennsylvania--(Newsfile Corp. - April 26, 2023) - Kaskela Law LLC announces that it is investigating Privia Health Group, Inc. ("Privia") (NASDAQ: PRVA) on behalf of the company's shareholders.
Since September 2022, shares of Privia's common stock have declined in value from a trading price of over $41.00 per share to a current trading price of less than $30.00 per share, a cumulative decline of over 25% in value.
The investigation seeks to determine whether Privia and/or the company's representatives violated the securities laws by issuing false and/or misleading statements, or by failing to disclose material information, to Privia shareholders, thereby causing investor losses.
Privia stockholders are encouraged to contact Kaskela Law LLC (Adrienne Bell, Esq.) at (484) 229 - 0750, or by email (abell@kaskelalaw.com) or online at https://kaskelalaw.com/cases/privia-health-group/, for additional information about this investigation and their legal rights and options.
Kaskela Law LLC exclusively represents investors in securities fraud, corporate governance, and merger & acquisition litigation. For additional information about Kaskela Law LLC please visit www.kaskelalaw.com.
CONTACT:
KASKELA LAW LLC
D. Seamus Kaskela, Esq.
Adrienne Bell, Esq.
18 Campus Blvd., Suite 100
Newtown Square, PA 19073
(888) 715 - 1740
(484) 229 - 0750
www.kaskelalaw.com
This notice may constitute attorney advertising in certain jurisdictions.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/163768
Published by: Newsfile Corp .